MktsMarkets

AnaptysBio, Inc.
NASDAQ: ANABKey statistics
ANAB News
Stories mentioning ANAB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 25,556 | 108,249 | 76,320 | 22,263 | 27,771 | 43,113 | 30,017 | 10,971 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 31,407 | 37,824 | 41,180 | 42,212 | 41,997 | |||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 60,193 | 41,348 | 41,616 | 48,433 | 55,310 | 52,783 | 52,774 | 51,292 |
| Operating Income (Loss) | (34,637) | 66,901 | 34,704 | (26,170) | (27,539) | (9,670) | (22,757) | (40,321) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (1.00) | (3.00) | 0.00 | 3,531 | 1,902 | 21.00 | (5.00) | 0.00 |
| Pretax Income | (52,844) | 49,695 | 15,113 | (38,591) | (39,285) | (21,790) | (32,851) | (46,651) |
| Tax Provision | 40.00 | 81.00 | 0.00 | 39.00 | 44.00 | (6.00) | 0.00 | 9.00 |
| Net Income (Loss) | (52,884) | 49,614 | 15,113 | (38,630) | (39,329) | (21,784) | (32,851) | (46,660) |
| Earnings Per Share (Basic) | (1.84) | 1.73 | 0.54 | (1.34) | (1.28) | (0.77) | (1.14) | (1.71) |
| Earnings Per Share (Diluted) | (1.84) | 1.73 | 0.52 | (1.34) | (1.28) | (0.77) | (1.14) | (1.71) |
| Weighted Average Shares Outstanding (Basic) | 28,691 | 28,758 | 27,833 | 28,810 | 30,644 | 28,382 | 28,893 | 27,356 |
| Weighted Average Shares Outstanding (Diluted) | 28,691 | 28,758 | 29,018 | 28,810 | 30,644 | 28,382 | 28,893 | 27,356 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ANAB
AnaptysBio, Inc. (NASDAQ: ANAB) is a stock listed on the Nasdaq Stock Market under the ticker symbol ANAB. It last traded at $47.73 (Nov 3, 2026, 4:00 PM ET), up 1.8% on the day. That gives AnaptysBio a market capitalisation of $1.4B and a price-to-earnings ratio of 7.3.
Over the past 52 weeks ANAB has traded between $20.18 and $72.36.
Revenue for the quarter ended Mar 31, 2026 was $25.6M; a net loss of $52.9M. Revenue was down 8.0% from $27.8M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $25.6M | -$52.9M | -206.9% |
| Dec 31, 2025 | $108.2M | $49.6M | 45.8% |
| Sep 30, 2025 | $76.3M | $15.1M | 19.8% |
| Jun 30, 2025 | $22.3M | -$38.6M | -173.5% |
From AnaptysBio’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…